The Children’s Cardiomyopathy Foundation is accepting Letters of Intent from investigators for basic science, clinical, population/epidemiologic, and translational research on cardiomyopathies affecting children age 18 and younger.
Grants of up to $50,000 will be awarded to studies focused on the causes, diagnosis, or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular, and left ventricular noncompaction cardiomyopathy. The grants are designed to provide seed funding to investigators for the testing of initial hypotheses and the collecting of preliminary data, with the goal of helping them secure long-term funding from the National Institutes of Health and other major granting institutions.
To be eligible, principal investigators must hold an M.D., Ph.D., or equivalent degree and reside in the United States or Canada. In addition, the PI must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Letters of Intent must be received no later than June 14, 2017. Upon review, selected applicants will be invited to submit a complete application by September 8, 2017.
See the CFF website for complete program guidelines and application instructions.